[Periocular hyperpigmentation following travoprost application].
Schmutz
J-L
JL
Service de dermatologie, hôpital Fournier, 36, quai de la Bataille, 54035 Nancy cedex, France. jl.schmutz@chu-nancy.fr
Barbaud
A
A
Tréchot
P
P
D000328:Adult; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D003008:Cloprostenol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005143:Eyelids; D005260:Female; D005500:Follow-Up Studies; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D051379:Mice; D008875:Middle Aged; D009798:Ocular Hypertension / Q000188:drug therapy*; D013997:Time Factors; D000069557:Travoprost
D000959:Antihypertensive Agents; D003008:Cloprostenol; D000069557:Travoprost